| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Corporate Controller
1 company
Bulis Veronica Sanchez serves as a VP, Corporate Controller at LYEL. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $212K at current prices.
Historically, Bulis Veronica Sanchez's trades have earned a middling insider score of 54/100 across 4 rated trades. On a 3-month view, 75.0% of the rated trades came out ahead, averaging +18.7% over three months.
The biggest single holding is LYEL (~$212K) as VP, Corporate Controller. The recent filings there lean toward selling, a net 3,403 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 621 | $14.34 | $8,905.14 | -4.0% | - | - | |
| May 11, 2026 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 217 | $18.91 | $4,103.47 | -1.4% | -25.4% | - | |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 254 | $23.12 | $5,872.48 | -1.6% | -19.0% | - | |
| Dec 30, 2025 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 2,072 | $35.80 | $74,180.64 | -22.5% | -38.9% | - | |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | VP, Corporate Controller | Sell | 239 | $16.10 | $3,847.90 | -2.5% | +31.5% | - |